Women with dual disorders: Clinical and treatment characteristics

Main Article Content

Rodrigo Marín-Navarrete
Ana de la Fuente-Martín
Gisel Cano-Arrieta
Luis Villalobos-Gallegos
Linda Bucay-Harari
Lorena Larios-Chávez
Ana Karen Ambriz-Figueroa

Abstract

Introduction: women with substance use disorders (SUD) are more likely to endorse dual disorders (DD) in comparison to men with the same condition, defining DD as the co-occurrence of SUD with other psychiatric disorders (OPD). This relationship causes negative consequences in the severity of the symptomatology and treatment of both conditions.


Objective: to analyze the clinical characteristics and treatment history of women with DD.


Method: psychiatric interview of women receiving treatment in two residential treatment centers. Disorders and their characteristics were compared in relation to previous treatments, GEE was used to determine the differences in medical prescriptions over time.


Results: data from 100 women was analyzed, 30 of them reported not having received any previous treatments, and less than 20% reported important medical illness. Women with borderline personality disorder had approximately a third of the odds of reporting previous treatments (OR=.33; IC 95% .13-.84). Significant differences were found in antidepressant (17.6% vs 41.8%; p<.05), mood stabilizers (12.1% vs 32.7%; p<.05), antipsychotics (15.4% vs 48.0%; p<.05), others (4.4% vs 29.6%; p<.05) over time.


Discussion and conclusions: this study represents an approximation based on the clinical evaluation of women with SUD and OPD, where the change in medical prescription over time might be related to the pharmacological treatment needs, which are not adequately treated.

Keywords:
dual disorders ,  residential treatment ,  pharmacological treatment
Published: Jan 1, 2015

Article Details

How to Cite
Marín-Navarrete, R., Fuente-Martín, A. de la, Cano-Arrieta, G., Villalobos-Gallegos, L., Bucay-Harari, L., Larios-Chávez, L., & Ambriz-Figueroa, A. K. (2015). Women with dual disorders: Clinical and treatment characteristics. Revista Internacional De Investigación En Adicciones, 1(1), 41–49. https://doi.org/10.28931/riiad.2015.1.06
Section
Original Articles

References

American Psychiatric Association. (2000). Diagnostic and Statical Manual of Mental Disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association.

Antai-Otong, D. (2006). Women and alcoholism: Gender-related medical complications: Treatment considerations. Journal of Addictions Nursing, 17(1), 33-45. doi: 10.1080/10884600500505828

Bagnardi, V., Blangiardo, M., La Vecchia, C., & Corrao, G. (2001). Alcohol consumption and the risk of cancer: A meta-analysis. Alcohol Research and Health, 25(4), 263–270.

Baño R. M. D. (2001). Uso de la olanzapina en el tratamiento del abuso de drogas estimulantes: una revisión. Trastornos adictivos, 3(2), 33-40.

Bernstein, D. P. (2000). Childhood trauma and drug addiction: Assessment, diagnosis, and treatment. Alcoholism Treatment Quarterly, 18(3), 19-30.

Blume, S. B., Frances, R., & Miller, S. (1998). Clinical Textbook of Addictive Disorders. (413–429). New York, NY: The Guilford Press.

Carey, M. P., Carey, K. B., Maisto, S. A., Gordon, C. M., & Vanable, P. A. (2001). Prevalence and correlates of sexual activity and HIV-related risk behavior among psychiatric outpatients. Journal of Consulting and Clinical Psychology, 69(5), 846.

Center for Substance Abuse Treatment. (2009). Substance Abuse Treatment: Addressing the Specific Needs of Women. Treatment Improvement Protocol (TIP) Series 51. HHS Publication No. (SMA) 09-4426. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Chiang, S. C., Chan, H. Y., Chang, Y. Y., Sun, H. J., Chen, W. J., & Chen, C. K. (2007). Psychiatric comorbidity and gender < difference among treatment‐seeking heroin abusers in Taiwan. Psychiatry and Clinical Neurosciences, 61(1), 105-111. doi: 10.1111/j.1440-1819.2007.01618.x

Chisholm, D., Rehm, J., Van Ommeren, M., & Monteiro, M. (2004). Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. Journal of Studies on Alcohol, 65(6), 782-793.

Finkelstein, N. (1994). Treatment issues for alcohol and drug-dependent pregnant and parenting women. Health & Social Work, 19(1), 7–15. doi: 10.1093/hsw/19.1.7

Flannery, B., Fishbein, D., Krupitsky, E., Langevin, D., Verbitskaya, E., Bland, C.,… Zvartau, E. (2007). Gender differences in neurocognitive functioning among alcohol-dependent Russian patients. Alcoholism: Clinical & Experimental Research, 31(5), 745–754. doi: 10.1111/j.1530-0277.2007.00372.x

Galván, J., & Marín-Navarrete, R. (2010). Sobre la atención a mujeres usuarias de drogas: cifras, barreras y modelos de tratamiento. En M. P. Romero, M. E. Medina-Mora, J. C. Rodriguez (Eds.), Mujeres y adicciones. México: INP, CONADIC, INMujeres.

Gomberg, E.S. (1989). Suicide risk among women with alcohol problems. American Journal of Public Health, 79, 1363–1365. doi: 10.2105/AJPH.79.10.1363

Grant, B. F. (1996). Toward an alcohol treatment model: A comparison of treated and untreated respondents with DSM -IV alcohol use disorders in the general population. Alcoholism: Clinical and Experimental Research, 20, 372-378.

Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., ... Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86(1), 1-21. doi: 10.1016/j.drugalcdep.2006.05.012

Grella, C.E. (1997). Services for perinatal women with substance abuse and mental health disorders: The unmet need. Journal of Psychoactive Drugs, 28(4),319–343.

Hernández-Ávila, C. A., Rounsaville, B.J., & Kranzler, H.R. (2004). Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74, 265– 272. doi: 10.1016/J.drugalcdep. 02.001

Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348-358. doi: 10.1016/J.blopsych.2006.03.040

Johnson, P.B., Richter, L., Kleber, H.D., McLellan, A.T., & Carise, D. (2005). Telescoping of drinking-related behaviors: Gender, racial/ethnic, and age comparisons. Substance Use & Misuse, 40(8),1139– 1151.

Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17-31.

Key, J., Hodgson, S., Omar, R.Z., Jensen, T.K., Thompson, S.G., Boobis, A.R., … Elliott, P. (2006). Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes and Control, 17(6), 759–770. doi: 10.1007/s10552-006-0011-0

Lynch, W. J., Roth, M. E., & Carroll, M. E. (2002). Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology, 164(2), 121-137.

Mann, K., Ackermann, K., Croissant, B., Mundle, G., Nakovics, H., & Diehl, A. (2005). Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?. Alcoholism: Clinical and Experimental Research, 29(5), 896-901.

Marín-Navarrete, R., & Medina-Mora, M.E. (2015). Comorbilidades en los trastornos por consumo de sustancias: un desafío para los servicios de salud en México. En: M.E. Medina-Mora (comp), La depresión y otros trastornos psiquiátricos. (pp. 39-58). México: Academia Nacional de Medicina de México, A. C.

Marín-Navarrete, R., Benjet, C., Borges, G., Eliosa-Hernández, A., Nanni-Alvarado, R., Ayala-Ledesma, M., ... Medina-Mora, M. E. (2013). Comorbilidad de los trastornos por consumo de sustancias con otros trastornos psiquiátricos en Centros Residenciales de Ayuda-Mutua para la Atención de las Adicciones. Salud Mental, 36(6), 471-479.

Marín-Navarrete, R., Eliosa-Hernández, A., Lozano-Verduzco, I., Turnbull, B., & Tena-Suck, A. (2013). Estudio sobre la experiencia de hombres atendidos en centros residenciales de ayuda mutua para la atención de las adicciones. Salud Mental, 36(5), 393-402.

Martín-Santos, R., Fonseca, F., Domingo-Salvany, A., Ginés, J. M., Ímaz, M. L., Navinés, R., ... Torrens, M. (2006). Dual diagnosis in the psychiatric emergency room in Spain. The European Journal of Psychiatry, 20(3), 147-156.

Martinotti, G., Lupi, M., Sarchione, F., Santacroce, R., Salone, A., De Berardis, D., ... Di Giannantonio, M. (2014). The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview. Current Pharmaceutical Design, 19(35), 6367-6374.

Medina-Mora, M. E., Borges, G., Muñiz, C. L., Benjet, C., & Jaimes, J. B. (2003). Resultados de la encuesta nacional de epidemiología psiquiátrica en México. Salud Mental, 26(4), 1.

Miquel, L., Roncero, C., López-Ortiz, C., & Casas, M. (2011). Diferencias de género, epidemiológicas y diagnósticas según eje I en pacientes con patología dual. Adicciones, 23(2), 165-172.

Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1997). The link between substance abuse and post-traumatic stress disorder in women: A research review. American Journal on Addictions, 6, 273–283.

Padwa, H., Larkins, S., Crevecoeur-MacPhail, D. A., & Grella, C. E. (2013). Dual diagnosis capability in mental health and substance use disorder treatment programs. Journal of Dual Diagnosis, 9(2), 179-186.

Pettinati, H. M., Oslin, D. W., Kampman, K. M., Dundon, W. D., Xie, H., Gallis, T. L., ... O’Brien, C. P. (2010). A double-blind, placebo- controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. American Journal of Psychiatry, 167(6), 668-675. doi: 10.1176/appi. ajp.2009.08060852

Piazza, N. J., Vrbka, L.L., & Yeager, R. D. (1989). Telescoping of alcoholism in women alcoholics. International Journal of Addictions, 24, 19-28.

Piran, N., & Robinson, S.R. (2006). Associations between disordered eating behaviors and licit and illicit substance use and abuse in a university sample. Addictive Behaviors, 31(10), 1761–1775. doi: 10.1016/j.addbeh.2005.12.021

Roncero, C., Fuste, G., Barral, C., Rodríguez-Cintas, L., Martínez-Luna, N., Eiroa-Orosa, F. J., & Casas, M. (2011). Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study. Heroin Addiction & Related Clinical Problems, 13(3), 5-16.

Roncero, C., Ramos, J.A., Collazos, F., & Casas, M. (2002). Complicaciones psicóticas del consumo de cocaína. Adicciones, 13(S2), 179-190

Sáiz-Martínez, P.A., Treviño, L.J., Mesa, E.M.D., González, M.P.G.P., González, P.M., Díaz, S.A. H., ... Ruiz, P. (2014). Patología dual en trastornos de ansiedad: recomendaciones en el tratamiento farmacológico. Adicciones: Revista de socidrogalcohol, 26(3), 254-274.

Sampson, H.W. (2002). Alcohol and other factors affecting osteoporosis risk in women. Alcohol Research & Health, 26(4), 292–298.

Secretaría de Salud, Centro Nacional para la Prevención de las Adicciones, Comisión Nacional contra las Adicciones, Instituto Nacional de Salud Pública, Instituto Nacional de Psiquiatría. (2012). Encuesta Nacional de Adicciones 2011. México: Autor.

Sohrabji, F. (2002). Neurodegeneration in women. Alcohol Research & Health, 26(4), 316–318

Szerman, N., Lopez-Castroman, J., Arias, F., Morant, C., Babín, F., Mesías, B., … Baca-García, E. (2012). Dual diagnosis and suicide risk in a Spanish outpatient sample. Substance Use & Misuse, 47(4), 383-389. doi: 10.3109/10826084.2011.636135

Szerman, N., Martínez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & their Treatment, 12(1), 1-10. doi: 10.1097/ADT.0b013e31826e7b6a

Szerman, N., Martinez-Raga, J., Roncero, C., Vega, P., Basurte-Villamor, I., Marín-Navarrete, R., … Casas, M. (2015). Key points on dual disorders/co-occurring disorders: addiction and other mental illnesses: A blueprint for a deep debate. On publisht results.

Tiemersma, E.W., Wark, P.A., Ocke, M.C., Bunschoten, A., Otten, M.H., Kok, F.J., & Kampman, E. (2003). Alcohol Consumption, Alcohol Dehydrogenase 3 Polymorphism and Colorectal Adenomas. Cancer Epidemiology Biomarkers Prevention, 12(5), 419–425.

Tolin, D.F., & Foa, E.B. (2006). Sex differences in trauma and posttraumatic stress disorder: A quantitative review of 25 years of research. Psychological Bulletin, 132(6), 959–992. doi: 10.1037/0033- 2909.132.6.959

Torrens, M. (2008). Patología dual: situación actual y retos de futuro. Adicciones, 20(4): 315-319.

Van Olphen, J. & Freudenberg, N. (2004). Harlem service providers’ perceptions of the impact of municipal policies on their clients with substance use problems. Journal of Urban Health, 81(2), 222-231.

Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2003). The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry, 160(2), 274- 283 doi: 10.1176/appi.ajp.160.2.274

Zeger, S. L., & Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42, 121-130. doi: 10.2307/2531248

Zilberman, M. L., Tavares, T., Blume, S. B., & el-Guebaly. (2003). Substance use disorders: Sex differences and psychiatric comorbidities. The Canadian Journal of Psychiatry / La Revue Cannadienne de Psychiatrie, 48(1), 5-3.

Zlotnick, C., Clarke, J. G., Friedmann, P. D., Roberts, M. B., Sacks, S., & Melnick, G. (2008). Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs. Behavioral Sciences & the Law, 26(4), 403-412. doi: 10.1002/bsl.831